Infectious bovine keratoconjunctivitis vaccine development

Australian Veterinary Journal

Volumn 83, Issue 8, 2005, Pages 506-510

  McConnel, C S ^a   House, J K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOS TAURUS; BOVINAE; MORAXELLA BOVIS;

BACTERIAL VACCINE;

ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; IMMUNOLOGY; KERATOCONJUNCTIVITIS; MORAXELLA; MORAXELLACEAE INFECTION; REVIEW; VACCINATION;

ANIMALS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; KERATOCONJUNCTIVITIS, INFECTIOUS; MORAXELLA; MORAXELLACEAE INFECTIONS; VACCINATION;

EID: 26944499102     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2005.tb13306.x     Document Type: Review

References (75)

1. Barner RD. A study of Moraxella bovis and its relation to bovine keratitis. Am J Vet Res 1952;13:132-144.
2. Henson JB, Grumbles LC. Infectious bovine keratoconjunctivitis. I. Etiology. Am J Vet Res 1960;21:761-766.
3. Marrion RM, Riley LK. Detection of cell detachment activity induced by Moraxella bovis. Am J Vet Res 2000;61:1145-1149.
4. Shryock TR, White DW, Werner CS. Antimicrobial susceptibility of Moraxella bovis. Vet Microbiol 1998;61:305-309.
5. Brown MH, Brightman AH, Fenwick BW, et al. Infectious bovine keratoconjunctivitis: a review. J Vet Intern Med 1998;12:259-266.
6. Yu RH, Schryvers AB. Bacterial lactoferrin receptors: insights from characterizing the Moraxella bovis receptors. Biochem Cell Biol 2002;80:81-90.
7. Angelos JA, Hess JF, George LW. Cloning and characterisation of a Moraxella bovis cytotoxin gene. Am J Vet Res 2001;62:1222-1228.
8. Pugh GW, Jr., Hughes DE. Experimental bovine infectious keratoconjunctivitis caused by sunlamp irradiation and Moraxella bovis infection: correlation of hemolytic ability and pathogenicity. Am J Vet Res 1968;29:835-839.
9. Beard MK, Moore LJ. Reproduction of bovine keratoconjunctivitis with a purified haemolytic and cytotoxic fraction of Moraxella bovis. Vet Microbiol 1994;42:15-33.
10. Kagonyera GM, George LW, Munn R. Cytopathic effects of Moraxella bovis on cultured bovine neutrophils and corneal epithelial cells. Am J Vet Res 1989;50:10-17.
11. Frank SK, Gerber JD. Hydrolytic enzymes of Moraxella bovis. J Clin Microbiol 1981;13:269-271.
12. Farn JL, Strugnell RA, Hoyne PA, et al. Molecular characterisation of a secreted enzyme with phospholipase B activity from Moraxella bovis. J Bacteriol 2001;183:6717-6720.
13. Arora AK, Killinger AH, Mansfield ME. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves. Am J Vet Res 1976;37:803-805.
14. Gil-Turnes C. Hemagglutination, autoagglutination and pathogenicity of Moraxella bovis strains. Can J Comp Med 1983;47:503-504.
15. Moore LJ, Rutter JM. Antigenic analysis of fimbrial proteins from Moraxella bovis. J Clin Microbiol 1987;25:2063-2070.
16. Jayappa HG, Lehr C. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves. Am J Vet Res 1986;47:2217-2221.
17. Ruehl WW, Marrs C, Beard MK, et al. Q pili enhance the attachment of Moraxella bovis to bovine corneas in vitro. Mol Microbiol 1993;7:285-288.
18. Ruehl WW, Marrs CF, Fernandez R, et al. Purification, characterisation, and pathogenicity of Moraxella bovis pili. J Exp Med 1988;168:983-1002.
19. Pedersen KB, Froholm LO, Bovre K. Fimbriation and colony type of Moraxella bovis in relation to conjunctival colonisation and development of keratoconjunctivitis in cattle. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1972;80:911-918.
20. Pugh GW, Jr., Hughes DE. Experimental production of infectious bovine keratoconjunctivitis: comparison of serological and immunological responses using pili fractions of Moraxella bovis. Can J Comp Med 1976;40:60-66.
21. Moore LJ, Lepper AW. A unified serotyping scheme for Moraxella bovis. Vet Microbiol 1991;29:75-83.
22. Mattick JS, Bills MM, Anderson BJ, et al. Morphogenetic expression of Bacteroides nodosus fimbriae in Pseudomonas aeruginosa. J Bacteriol 1987;169:33-41.
23. Lepper AW, Atwell JL, Lehrbach PR, et al. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Vet Microbiol 1995;45:129-138.
24. Clinkenbeard KD, Thiessen AE. Mechanism of action of Moraxella bovis hemolysin. Infect Immun 1991;59:1148-1152.
25. Billson FM, Harbour C, Michalski WP, et al. Characterisation of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody. Infect Immun 2000;68:3469-3474.
26. Angelos JA, Hess JF, George LW. An RTX operon in hemolytic Moraxella bovis is absent from nonhemolytic strains. Vet Microbiol 2003;92:363-377.
27. George LW, Angelos JA, Ruehl WW. Stability, antigenicity, and aggregation of Moraxella bovis cytolysin after purification and storage. Am J Vet Res 2004;65:977-983.
28. Rogers DG, Cheville NF, Pugh GW, Jr. Pathogenesis of corneal lesions caused by Moraxella bovis in gnotobiotic calves. Vet Pathol 1987;24:287-295.
29. Pugh GW, Jr., Kopecky KE, Kvasnicka WG, et al. Infectious bovine keratoconjunctivitis in cattle vaccinated and medicated against Moraxella bovis before parturition. Am J Vet Res 1982;43:320-325.
30. Smith PC, Greene WH. Antibodies related to resistance in bovine pinkeye. Calif Vet 1989;43:7-10.
31. Arora AK, Killinger AH, Myers WL. Detection of Moraxella bovis antibodies in infectious bovine keratoconjunctivitis by a passive hemagglutination test. Am J Vet Res 1976;37:1489-1492.
32. Nayar PS, Saunders JR. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis. Can J Comp Med 1975;39:32-40.
33. Kopecky KE, Pugh GW, Jr., McDonald TJ. Infectious bovine keratoconjunctivitis: evidence for general immunity. Am J Vet Res 1983;44:260-262.
34. Hughes DE, Pugh GW, Jr. Experimentally induced bovine infectious keratoconjunctivitis: effectiveness of intramuscular vaccination with viable Moraxella bovis culture. Am J Vet Res 1971;32:879-886.
35. Baptista PJHP. Bovine infectious keratoconjunctivitis. I. Resistance of cattle vaccinated with live Moraxella bovis to challenge with homologous or heterologous strains. II. Aetiology. III. Immunology. [Portuguese]. Boletim do Instituto de Pesquisas Veterinarias "Desiderio Finamor" 1975;3:5-16, 17-27, 29-35.
36. Hughes DE, Pugh GW, Jr. Experimentally induced infectious bovine keratoconjunctivitis: vaccination with nonviable Moraxella bovis culture. Am J Vet Res 1972;33:2475-2479.
37. Pugh GW, Jr., Hughes DE, Schulz VD, et al. Experimentally induced infectious bovine keratoconjunctivitis: resistance of vaccinated cattle to homologous and heterologous strains of Moraxella bovis. Am J Vet Res 1976;37:57-60.
38. Pugh GW, Jr., McDonald TJ, Kopecky KE. Experimental infectious bovine keratoconjunctivitis: efficacy of a vaccine prepared from nonhemolytic strains of Moraxella bovis. Am J Vet Res 1982;43:1081-1084.
39. Lepper AW. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis. Aust Vet J 1988;65:310-316.
40. Prieto CI, Aguilar OM, Yantorno OM. Analyses of lipopolysaccharides, outer membrane proteins and DMA fingerprints reveal intraspecies diversity in Moraxella bovis isolated in Argentina. Vet Microbiol 1999;70:213-223.
41. Kakuda T, Oishi D, Tsubaki S, et al. Molecular cloning and characterisation of a 79-kDa iron-repressible outer-membrane protein of Moraxella bovis. FEMS Microbiol Lett 2003;225:279-284.
42. Ostle AG, Rosenbusch RF. Outer membrane protein antigens of Moraxella bovis. Am J Vet Res 1986;47:1419-1421.
43. Billson FM, Hodgson JL, Egerton JR, et al. A haemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis. FEMS Microbiol Lett 1994;124:69-73.
44. Lehr C, Jayappa HG, Goodnow RA. Serologic and protective characterisation of Moraxella bovis pili. Cornell Vet 1985;75:484-492.
45. Lepper AW, Moore LJ, Atwell JL, et al. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis. Vet Microbiol 1992;32:177-187.
46. Lepper AW, Elleman TC, Hoyne PA, et al. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis. Vet Microbiol 1993;36:175-183.
47. Conceicao FR, Paolicchi F, Cobo AL, et al. Antigenic relationships of Moraxella bovis isolates recovered from outbreaks of infectious bovine keratoconjunctivitis in Argentina, Brazil, and Uruguay between 1983 and 2000. Can J Vet Res 2003;67:315-318.
48. Lehr C, Jayappa HG, Goodnow RA. Controlling bovine keratoconjunctivitis with a piliated Moraxella bovis bacterin. Vet Med 1985;80:96-100.
49. Bateman KG, Leslie KE, Scholl TP. A field trial of a piliated Moraxella bovis bacterin for the prevention of infectious bovine keratoconjunctivitis. Can Vet J 1986;27:23-27.
50. Smith PC, Blankenship T, Hoover TR, et al. Effectiveness of two commercial infectious bovine keratoconjunctivitis vaccines. Am J Vet Res 1990;51:1147-1150.
51. Gil-Turnes C, Albuquerque IM. Serotypes and antibiotic sensitivity of Moraxella bovis isolated from an outbreak of infectious bovine keratoconjunctivitis. Can J Comp Med 1984;48:428-430.
52. Lepper AW, Hermans LR. Characterisation and quantitation of pilus antigens of Moraxella bovis by ELISA. Aust Vet J 1986;63:401-405.
53. Davidson HJ, Stokka GL. A field trial of autogenous Moraxella bovis bacterin administered through either subcutaneous or subconjunctival injection on the development of keratoconjunctivitis in a beef herd. Can Vet J 2003;44:577-580.
54. Vandergaast N, Rosenbusch RF. Infectious bovine keratoconjunctivitis epizootic associated with area-wide emergence of a new Moraxella bovis pilus type. Am J Vet Res 1989;50:1437-1441.
55. Greene WH, Grubbs ST, Potgieter LN. Detection of shared magnetic antigenic determinants on whole Moraxella bovis pili by use of antisera to cyanogen bromide-cleaved M. bovis pilus protein. Am J Vet Res 2001;62:1279-1284.
56. Ruehl WW, Marrs CF, George L, et al. Infection rates, disease frequency, pilin gene rearrangement, and pilin expression in calves inoculated with Moraxella bovis pilin-specific isogenic variants. Am J Vet Res 1993;54:248-253.
57. Greene WH, Grubbs ST, Potgieter LN. Immunoblot analysis of cyanogen bromide-cleaved Moraxella bovis pilin reveals presence of shared antigenic determinants on pili from heterologous strains. Vet Microbiol 2001;80:365-372.
58. Hoien-Dalen PS, Rosenbusch RF, Roth JA. Comparative characterisation of the leukocidic and hemolytic activity of Moraxella bovis. Am J Vet Res 1990;51:191-196.
59. Ostle AG, Rosenbusch RF. Immunogenicity of Moraxella bovis hemolysin. Am J Vet Res 1985;46:1011-1014.
60. Ostle AG, Rosenbusch RF. Moraxella bovis hemolysin. Am J Vet Res 1984;45:1848-1851.
61. George LW, Borrowman AJ, Angelos JA. Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis. Am J Vet Res 2005;66:136-142.
62. Angelos JA, Hess JF, George LW. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine. Vaccine 2004;23:537-545.
63. Lepper AW, Power BE. Infectivity and virulence of Australian strains of Moraxella bovis for the murine and bovine eye in relation to pilus serogroup subunit size and degree of piliation. Aust Vet J 1988;65:305-309.
64. McNamara PJ, Bradley GA, Songer JG. Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis. Mol Microbiol 1994;12:921-930.
65. Fenwick B. Rider M, Liang J, et al. Iron repressible outer membrane proteins of Moraxella bovis and demonstration of siderophore-like activity. Vet Microbiol 1996;48:315-324.
66. Kakuda T, Oishi D, Tsubaki S, et al. Cloning and characterisation of the fur gene from Moraxella bovis. Microbiol Immunol 2003;47:411-417.
67. Du R, Wang Q, Yang Y-P, et al. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect Immun 1998;66:3656-3664.
68. Misiura M. Estimation of fimbrial vaccine effectiveness in protection against keratoconjunctivitis infectiosa in calves considering different routes of introducing vaccine antigene. Arch Vet Pol 1994;34:177-186.
69. Pedersen KB. The origin of immunoglobulin-G in bovine tears. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1973;81:245-252.
70. Webber JJ, Selby LA. Effects of Moraxella bovis vaccination schedules on experimentally induced infectious bovine keratoconjunctivitis. Am J Vet Res 1981;42:1181-1183.
71. Misiura M. Keratoconjunctivitis infectiosa in calves - attempt at elimination by active immunisation. Arch Vet Pol 1994;34:187-194.
72. Maidment DC, Batty DL. Changes in titres of Moraxella boviss-specific IgG in growing cattle. Br Vet J 1986;142:65-69.
73. Conceicao FR, Dellagostin OA, Paolichi F, et al. Molecular diversity of Moraxella bovis isolated from Brazil, Argentina and Uruguay over a period of three decades. Vet J 2004;167:53-58.
74. Gil-Turnes C, de Araujo FL. Serological characterisation of strains of Moraxella bovis using double immunodiffusion. Can J Comp Med 1982;46:165-168.
75. Prieto CI, Rodriguez ME, Bosch A, et al. Whole-bacterial cell enzyme-linked immunosorbent assay for cell-bound Moraxella bovis pili. Vet Microbiol 2003;91:157-168.